ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 64 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $65,133 | -23.4% | 122,892 | +5.2% | 0.01% | -31.6% |
Q3 2022 | $85,000 | -66.8% | 116,780 | -47.9% | 0.02% | -62.7% |
Q2 2022 | $256,000 | -41.6% | 224,221 | +5.0% | 0.05% | -28.2% |
Q1 2022 | $438,000 | -25.3% | 213,469 | +4.9% | 0.07% | -21.1% |
Q4 2021 | $586,000 | -25.3% | 203,509 | +10.0% | 0.09% | -25.0% |
Q3 2021 | $784,000 | -84.6% | 184,935 | -80.8% | 0.12% | -84.6% |
Q2 2021 | $5,092,000 | +51.8% | 962,632 | +33.4% | 0.78% | +31.8% |
Q1 2021 | $3,355,000 | +1309.7% | 721,587 | +899.9% | 0.59% | +974.5% |
Q4 2020 | $238,000 | +128.8% | 72,169 | +128.7% | 0.06% | +77.4% |
Q3 2020 | $104,000 | +153.7% | 31,552 | +156.8% | 0.03% | +121.4% |
Q2 2020 | $41,000 | – | 12,286 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ETF MANAGERS GROUP, LLC | 2,679,457 | $20,257,000 | 0.73% |
Portolan Capital Management | 777,293 | $5,876,000 | 0.66% |
CAMPBELL CAPITAL MANAGEMENT INC | 110,451 | $835,000 | 0.62% |
ZEKE CAPITAL ADVISORS, LLC | 402,212 | $3,041,000 | 0.27% |
Leap Investments LP | 46,084 | $348,000 | 0.17% |
Bernardo Wealth Planning LLC | 26,419 | $199,000 | 0.14% |
Claraphi Advisory Network, LLC | 14,744 | $111,000 | 0.07% |
Sterling Investment Advisors, Ltd. | 11,000 | $83,000 | 0.04% |
A.R.T. Advisors, LLC | 81,372 | $615,000 | 0.03% |
Mirae Asset Global Investments Co., Ltd. | 544,408 | $4,116,000 | 0.03% |